Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

HIV Infection

Free Subscription 22.02.2010 9 AIDS 15 AIDS Res Hum Retroviruses 1 Antimicrob Agents Chemother 1 Blood 4 Clin Infect Dis 3 HIV Med 2 J Acquir Immune Defic Syndr 1 J Med Virol 3 J Virol 5 Lancet 1 N Engl J Med 1 Pediatr Infect Dis J 1 Pediatrics 1 Proc Natl Acad Sci U S A 2 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. CHARPENTIER C , Laureillard D, Piketty C, Tisserand P, et al
   High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.
   AIDS. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
2. RADZIO J , Yap SH, Tachedjian G, Sluis-Cremer N, et al
   N348I in reverse transcriptase provides a genetic pathway for HIV-1 to select thymidine analogue mutations and mutations antagonistic to thymidine analogue mutations.
   AIDS. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
3. GATANAGA H , Ode H, Hachiya A, Hayashida T, et al
   Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance.
   AIDS. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
4. CHOI BS , Lee HS, Oh YT, Hyun YL, et al
   Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1.
   AIDS. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
5. MORRISON CS , Demers K, Kwok C, Bulime S, et al
   Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection.
   AIDS. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
6. DODD PJ , Garnett GP, Hallett TB
   Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
   AIDS. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
7. TUMA P , Jarrin I, Del Amo J, Vispo E, et al
   Survival of HIV-infected patients with compensated liver cirrhosis.
   AIDS. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
8. NOZZA S , Galli L, Visco F, Soria A, et al
   Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience.
   AIDS. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
9. BAMFORD LP , Ehrenkranz PD, Eberhart MG, Shpaner M, et al
   Factors associated with delayed entry into primary HIV medical care after HIV diagnosis.
   AIDS. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   AIDS Res Hum Retroviruses

10. BORTOLIN MT , Zanussi S, Talamini R, Simonelli C, et al
    Predictive Value of HIV Type 1 DNA Levels on Overall Survival in HIV-Related Lymphoma Patients Treated with High-Dose Chemotherapy (HDC) Plus Autologous Stem Cell Transplantation (ASCT).
    AIDS Res Hum Retroviruses. 2010;26:245-51.
    PubMed     Text format     Related articles    Abstract available
    
    
11. GARCIA-MERINO I , de Las Cuevas N, Jimenez JL, Garcia A, et al
    Pediatric HIV BioBank: A New Role of the Spanish HIV BioBank in Pediatric HIV Research.
    AIDS Res Hum Retroviruses. 2010;26:241-4.
    PubMed     Text format     Related articles    Abstract available
    
    
12. SUN J , Ma L, Jiang S, Shao Y, et al
    HIV Type 1 B'/C Recombinant (CRF07_BC) in Virologic Noncontrollers Elicits Neutralizing Antibodies Against Heterologous But Not Autologous Viruses.
    AIDS Res Hum Retroviruses. 2010;26:237-9.
    PubMed     Text format     Related articles   
    
    
13. PHAN TT , Ishizaki A, Phung DC, Bi X, et al
    Characterization of HIV Type 1 Genotypes and Drug Resistance Mutations Among Drug-Naive HIV Type 1-Infected Patients in Northern Vietnam.
    AIDS Res Hum Retroviruses. 2010;26:233-5.
    PubMed     Text format     Related articles    Abstract available
    
    
14. FERREIRA FG , Pinto JA, Kakehasi FM, Cleto S, et al
    Prevalence of Primary Drug Resistance-Associated Mutations Among HIV Type 1 Vertically Infected Children in Belo Horizonte, Brazil.
    AIDS Res Hum Retroviruses. 2010;26:229-32.
    PubMed     Text format     Related articles    Abstract available
    
    
15. DE SILVA UC , Warachit J, Sattagowit N, Jirapongwattana C, et al
    Genotypic Characterization of HIV Type 1 env gp160 Sequences from Three Regions in Thailand.
    AIDS Res Hum Retroviruses. 2010;26:223-7.
    PubMed     Text format     Related articles    Abstract available
    
    
16. CHIN BS , Choi JY, Han Y, Kuang J, et al
    Comparison of Genotypic Resistance Mutations in Treatment-Naive HIV Type 1-Infected Patients in Korea and China.
    AIDS Res Hum Retroviruses. 2010;26:217-21.
    PubMed     Text format     Related articles    Abstract available
    
    
17. FOGLE JE , Mexas AM, Tompkins WA, Tompkins MB, et al
    CD4(+)CD25(+) T Regulatory Cells Inhibit CD8(+) IFN-gamma Production During Acute and Chronic FIV Infection Utilizing a Membrane TGF-beta-Dependent Mechanism.
    AIDS Res Hum Retroviruses. 2010;26:201-16.
    PubMed     Text format     Related articles    Abstract available
    
    
18. SPEAR GT , Gilbert D, Sikaroodi M, Doyle L, et al
    Identification of Rhesus Macaque Genital Microbiota by 16S Pyrosequencing Shows Similarities to Human Bacterial Vaginosis: Implications for Use as an Animal Model for HIV Vaginal Infection.
    AIDS Res Hum Retroviruses. 2010;26:193-200.
    PubMed     Text format     Related articles    Abstract available
    
    
19. ALI SA , Huang MB, Campbell PE, Roth WW, et al
    Genetic Characterization of HIV Type 1 Nef-Induced Vesicle Secretion.
    AIDS Res Hum Retroviruses. 2010;26:173-92.
    PubMed     Text format     Related articles    Abstract available
    
    
20. DONHAUSER N , Helm M, Pritschet K, Schuster P, et al
    Differential Effects of P-Class Versus Other CpG Oligodeoxynucleotide Classes on the Impaired Innate Immunity of Plasmacytoid Dendritic Cells in HIV Type 1 Infection.
    AIDS Res Hum Retroviruses. 2010;26:161-71.
    PubMed     Text format     Related articles    Abstract available
    
    
21. EGGINK LL , Salas M, Hanson CV, Hoober JK, et al
    Peptide Sugar Mimetics Prevent HIV Type 1 Replication in Peripheral Blood Mononuclear Cells in the Presence of HIV-Positive Antiserum.
    AIDS Res Hum Retroviruses. 2010;26:149-60.
    PubMed     Text format     Related articles    Abstract available
    
    
22. SIRIPASSORN K , Manosuthi W, Chottanapund S, Pakdee A, et al
    Effectiveness of Boosted Protease Inhibitor-Based Regimens in HIV Type 1-Infected Patients Who Experienced Virological Failure with NNRTI-Based Antiretroviral Therapy in a Resource-Limited Setting.
    AIDS Res Hum Retroviruses. 2010;26:139-48.
    PubMed     Text format     Related articles    Abstract available
    
    
23. ZARAGOZA-MACIAS E , Cosco D, Nguyen ML, Del Rio C, et al
    Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population.
    AIDS Res Hum Retroviruses. 2010;26:133-8.
    PubMed     Text format     Related articles    Abstract available
    
    
24. TOVANABUTRA S , Sanders EJ, Graham SM, Mwangome M, et al
    Evaluation of HIV Type 1 Strains in Men Having Sex with Men and in Female Sex Workers in Mombasa, Kenya.
    AIDS Res Hum Retroviruses. 2010;26:123-31.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Antimicrob Agents Chemother

25. VAN 'T KLOOSTER G , Hoeben E, Borghys H, Looszova A, et al
    Nanosuspension of rilpivirine (TMC278) as a long-acting injectable antiretroviral formulation: pharmacokinetics and disposition.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Blood

26. LOKE P , Favre D, Hunt PW, Leung JM, et al
    Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from non-controllers.
    Blood. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Clin Infect Dis

27. LLIBRE JM , Schapiro JM, Clotet B
    Clinical Implications of Genotypic Resistance to the Newer Antiretroviral Drugs in HIV-1-Infected Patients with Virological Failure.
    Clin Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
28. COTTON MF , Rabie H, van Zyl GU
    Another Milestone in Minimizing Risks to Mothers Exposed to Single-Dose Nevirapine for Prevention of Vertical Transmission of HIV-1 to Infants: What Next?
    Clin Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
29. LALLEMANT M , Ngo-Giang-Huong N, Jourdain G, Traisaithit P, et al
    Efficacy and Safety of 1-Month Postpartum Zidovudine-Didanosine to Prevent HIV-Resistance Mutations after Intrapartum Single-Dose Nevirapine.
    Clin Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
30. MCMAHON D , Jones J, Wiegand A, Gange SJ, et al
    Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy.
    Clin Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    HIV Med

31. KABAMBA-MUKADI B , Duquenne A, Henrivaux P, Musuamba F, et al
    HIV-1 proviral resistance mutations: usefulness in clinical practice.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
32. BEDIMO R , Westfall AO, Mugavero M, Drechsler H, et al
    Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
33. ENGSIG F , Omland L, Larsen M, Rasmussen L, et al
    Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.
    HIV Med. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    J Acquir Immune Defic Syndr

34. PROMADEJ-LANIER N , Hanson DL, Srinivasan P, Luo W, et al
    Resistance to Simian HIV Infection Is Associated With High Plasma Interleukin-8, RANTES and Eotaxin in a Macaque Model of Repeated Virus Challenges.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
35. MANTINA H , Wiggill TM, Carmona S, Perner Y, et al
    Characterization of Lymphomas in a High Prevalence HIV Setting.
    J Acquir Immune Defic Syndr. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    J Med Virol

36. DAMAY A , Fabre J, Costes V, Didelot JM, et al
    Human papillomavirus (HPV) prevalence and type distribution, and HPV-associated cytological abnormalities in anal specimens from men infected with HIV who have sex with men.
    J Med Virol. 2010;82:592-596.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    J Virol

37. UTACHEE P , Nakamura S, Isarangkura-Na-Ayuthaya P, Tokunaga K, et al
    Two N-linked glycosylation sites in V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for CD4 binding domain.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
38. MARTINS MA , Wilson NA, Reed JS, Ahn CD, et al
    T-cell correlates of vaccine efficacy after a heterologous SIV challenge.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
39. PINCETIC A , Kuang Z, Seo EJ, Leis J, et al
    The Interferon Induced Gene ISG15 Blocks Retrovirus Release from Cells Late in the Budding Process.
    J Virol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Lancet

40. MORRIS K
    Linda-Gail Bekker: confronting the TB/HIV co-infection epidemic.
    Lancet. 2010;375:545.
    PubMed     Text format     Related articles   
    
    
41. SIDIBE M , Buse K
    Fomenting a prevention revolution for HIV.
    Lancet. 2010;375:533-5.
    PubMed     Text format     Related articles   
    
    
42. BUVE A , Lynen L
    Treating HIV infection with drugs for HSV-2 infection?
    Lancet. 2010.
    PubMed     Text format     Related articles   
    
    
43. LINGAPPA JR , Baeten JM, Wald A, Hughes JP, et al
    Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
    Lancet. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
44. SINGH JA
    Organ transplantation between HIV-infected patients.
    Lancet. 2010;375:442-3.
    PubMed     Text format     Related articles   
    
    

    
    N Engl J Med

45. RADHAKRISHNAN J , Uppot RN, Colvin RB
    Case 5-2010 -- A 51-Year-Old Man with HIV Infection, Proteinuria, and Edema.
    N Engl J Med. 2010;362:636-46.
    PubMed     Text format     Related articles   
    
    

    
    Pediatr Infect Dis J

46. PALLADINO C , Briz V, Policarpo SN, Silveira LF, et al
    Long-Term Efficacy and Safety of Fosamprenavir in Human Immunodeficiency Virus-Infected Pediatric Patients.
    Pediatr Infect Dis J. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Pediatrics

47. SAHIN G , Palanduz A, Aydogan G, Cassar O, et al
    Classic Kaposi Sarcoma in 3 Unrelated Turkish Children Born to Consanguineous Kindreds.
    Pediatrics. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Proc Natl Acad Sci U S A

48. NCHINDA G , Amadu D, Trumpfheller C, Mizenina O, et al
    Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells.
    Proc Natl Acad Sci U S A. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Virology

49. SREENATH K , Pavithra L, Singh S, Sinha S, et al
    Nuclear Matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling.
    Virology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
50. FAITH SA , Wu Y, Kuhrt D, Steckbeck JD, et al
    Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation.
    Virology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: